Yellow Fever Vaccination and Its Necessary Guidelines for Travelers

Verified data

3 min read

Share
Facebook Telegram LinkedIn WhatsApp

Outline

The yellow fever vaccine provides lifetime immunity. Also, it helps to prevent disease spread.

Medically reviewed by Dr. Partha Sarathi Adhya
Published At November 23, 2023
Reviewed At November 23, 2023

Education:

PMC

Professional Bio:

DR. GAURAV GUPTA Address for correspondence SCF 30, Phase 3B2, Mohali, Punjab. Mobile: 09872303775. Email: docgaurav@gmail.com (Updated – May 2023) ________________________________________________________________________ ACADEMIC PROFILE Sr.No. Examination Year of Passing College & University 1 DNB (Peds) 1998 NBE, New Delhi. 2 DCH 1996 BJMC, University of Pune 3 MBBS 1994 BJMC, University of Pune Registration no. Maharashtra 75858 Punjab 39465 ________________________________________________________________________ WORK EXPERIENCE Sr.No. Place of Work Designation From - To 1 Charak Child Care MD, Consultant (Pediatrics) 2002 to Present 2 TravelSafe Clinic Founder,Travel Physician 2010 to Present 3 GAPCO Healthcare CoCreator, CHUBEARS gummy vitamins, Nutraceuticals 2014 to Present 4 Fortis, Mohali Consultant (Pediatrics) 2002 - 2009 5 Inscol Hospital Consultant (Pediatrics) 2007 - 2009 6 PGIMER, Chandigarh Senior Resident (Pediatrics) Oct, 1999 - Oct, 2002 7 GMCH, Chandigarh Senior Resident (Pediatrics) Aug, 1998 - Oct, 1999 ________________________________________________________________________ ADDITIONAL INFORMATION ØGood Clinical Practice (GCP) Certified - 2022 ØPresident IAP Chandigarh Tricity – 2021 ØMember EpiCore Certified – International Disease Surveillance Network. Epicore.org – 2015 to present ØMember, Scientific Advisory Board, GSK for Priorix Tetra Vaccine (Jan 2016) ØMember, Scientific Advisory Board, Sanofi Pasteur for Menactra (Sep 2016) ØExpert Resource Person, Vaccines. Completed IAP Advanced Vaccinology Course – Dec 2012, Gurgaon. ØDistrict Resource Person, Mohali. Completed Science of Vaccinology, Regional Workshop for Training in Vaccinology – August 2008, Chandigarh. ØContributing Editor for CLIPPINGS in INDIAN PEDIATRICS since July 2000 to Dec 2015 ØContributing Author for MDcurrent.in website – Global Medicine, Local Focus -2014 to present ØContributing Author for American Academy of Pediatrics Society for International Child Health Newsletter - 2017, 2018 ØMember American Academy of Pediatrics (AAP - 1052548) – 2012 to present ØMember Indian Academy of Pediatrics (L-1998/ G 630) – 1998 to present ØMember Punjab Medical Council (39465) & Maharashtra Medical Council (75858)- 2009 to present ØMember of various Professional International Travel Health Organizations including ISTM, ASTMH, BGTHA and IAMAT – 2010 to present ØOnline editor for HARRIET LANE Pediatric Links (http://derm.med.jhmi.edu/poi/Editors.cfm) ØTreasurer, IAP Chandigarh – 2012 to 2014 ØCo-guide M. Pharm students, NIPER, since 2009 to 2019. ØPALS Certified (Pediatric Advanced Life Support) course (1998) ØSub-specialty coordinator in Pediatrics for Indian Medical Informatics Association (1999-2000) ØWinner of Zonal level IAP PEDIQUIZ (1993) (Undergraduate) ØExecutive Member IAP Chandigarh - 2006 ØPULSE POLIO campaign coordinator for ZONE 1, Chandigarh (2000-2001 AND 2001-2002) under Prof Lata Kumar ________________________________________________________________________ PRESENTATIONS INTERNATIONAL 1.Tiwari P, Gupta G, Gundu M. Judicious use of anti-microbials: Evidence from real time setting. ESPID, May 2016, Brighton, UK. Poster no. ESP16-0547 2.Dobaria N, Gupta G, Tiwari P. Prevalence of adherence and need of nutritional supplements among paediatric population: A cross-sectional survey of parents. 14th Commonwealth Association of Pediatric Gastroenterology and Nutrition (CAPGAN 2015), Oct 2015, New Delhi. Nutrition, Poster no. N-8 3.Ahlawat R, Gupta G, Tiwari P. Does Seasonal Influenza Vaccine Provide Effectiveness In Toddlers? 5th Asian Vaccine Conference (ASVAC). Hanoi, Vietnam, June 12-14, 2015. ASVAC - 0069 4.Mounika G, Tiwari P, Gaurav G. Direct Cost Involved in the Treatment of Most Commonly Occurring Illness in Children at a Pediatric Outpatient Clinic In North India. ISPOR 19th Annual International Meeting, May 2014, Montreal Canada. PRS 34 5.Ahlawat R, Tiwari P, Gaurav G. Drug Prescribing Pattern in Private Pediatric Outpatient Clinic. ISPOR 19th Annual International Meeting, May 2014, Montreal Canada. PIH 83 6.Snehlata P, Tiwari P, Gaurav G. Safety & tolerability of Yellow Fever Vaccination in Indian Travelers – Early Results. 10th Asia Pacific Travel Health Conference. Ho Chi minh City, Vietnam, May 2014. APTHC-0793 7.Ahlawat R, Tiwari P, Gaurav G. Antibiotic Utilization in treatment of Upper Respiratory Tract Infections in children. 8th World Congress of the World Society for Pediatric Infectious Diseases (WSPID), Cape Town, South Africa, November, 2013. Abstract no. 0223 8.Ahlawat R, Tiwari P,Gaurav G. Effectiveness of influenza vaccine in Indian children for the season 2011-12. International Congress of Pediatrics 2013 (ICP) Melbourne, Australia. Aug, 2013. Abstract No- A-555-0008-01608. 9.Ahlawat R, Gaurav G, Tiwari P,. Survey of knowledge, attitude and practice of pediatricians regarding influenza vaccine in India. International Congress of Pediatrics 2013 (ICP), Melbourne, Australia, Aug, 2013. Abstract No- A-555-0018-01623. 10.Ahlawat R, Tiwari P, Gaurav G. Costing of drugs for treating reactive airways disease (RAD) at a private pediatric outpatient setting in northern India. Poster accepted at International Congress of Pediatrics 2013 (ICP), Melbourne, Australia. Aug, 2013. Abstract No- A-555-0009-01631. 11.Ahlawat R, Tiwari P, Gupta G. Cost analysis of antibiotics utilization in respiratory tract infection using prescribing indicators. 18th Annual ISPOR Meet at New Orleans, LA, USA. May, 2013; Abstract No. 42647. 12.Ahlawat R, Tiwari P, Gupta G. Safety and tolerability of yellow fever vaccine in Indian travellers. 13th Conference of International Society of Travel Medicine 2013 (CISTM-13), Maastricht, Netherland. May, 2013. Poster No- 133. 13.Ahlawat R, Tiwari P, Gupta G. Upper respiratory tract infections at a paediatric outpatient setting in North India. 6th Asian Congress of Pediatric Infectious Diseases (ACPID 2012), Colombo, Srilanka. Dec, 2012, Abstract no-67. 14.Ahlawat R, Tiwari P, Gupta G . Survey of Knowledge, Attitude and Practice of Paediatricians regarding influenza vaccine in India. 6th Asian Congress of Pediatric Infectious Diseases (ACPID 2012), Colombo, Srilanka. 28 Nov-1Dec, 2012, Abstract No-69. 15.Gaurav G, Ahlawat R, Tiwari P. Knowledge, attitude and practices of the Indian travelers receiving Yellow fever vaccination. 9th Asia Pacific travel health conference, Singapore. May, 2012. Abstract No- 139. 16.Ahlawat R, Tiwari P, Gaurav G. Safe use of antibiotics in respiratory tract infections at paediatric outpatient setting in northern India. International Conference on Patient Safety, NIPER. March, 2012. Abstract No- 7. 17.Ahlawat R, Tiwari P, Gaurav G. Safety & tolerability of Yellow fever vaccine in the healthy Indian travelers. International conference on patient safety, NIPER. March, 2012. Abstract No- 9. 18.G. Gupta, P. Tiwari, R. Renuka. Clinical Effectiveness of the Trivalent Influenza Vaccine 2010-2011 in healthy Indian children. 7th World Congress of the World Society for Pediatric Infectious Disease (WSPID) Melbourne, Australia. Nov 2011. Abstract no-139, Poster session 3. 19.Singh H, Gupta G, Tiwari P. Clinical Effectiveness of the Seasonal Influenza Vaccine 2009-2010 in healthy Indian children. 4th Asia-Pacific Conference of International Society for Pharmacoeconomics and Outcome Research (ISPOR) Phuket, Thailand. Sept 2010. Abstract no-27564 20.Gupta A, Gupta G, Tiwari P. Drug Utilization Review in Private Outpatient Pediatric Setting with special reference to Antimicrobial Drugs. 14th annual meeting of International Society for Pharmacoeconomics and Outcome Research (ISPOR) Orlando USA. May 2009. Abstract no-21410 21.Trehan A, Marwaha RK, Gupta G. Relevance of the Symptom-Diagnosis Interval in Childhood Acute Lymphoblastic Leukemia. Presented at SIOP (INTERNATIONAL Society of Pediatric Oncology) Conference (Oct 2000, Holland). Published as an abstract in Medical Hemato-oncology Journal NATIONAL 1.Tiwari P, Gupta G, Vora N, Assessment of compliance to Antimicrobial therapy in children and factors affecting it. 3rd Pediatric Conference of North India. New Delhi Dec 2016. Poster A.28 2.Ahlawat R, Tiwari P, Gupta G. Use of home remedies, nutritional supplements, and adherence to treatment regimen in children. Proceedings of the 2nd Pediatric conference of North India (PCNI); Sept, 2015; New Delhi: IAP West Delhi City Branch; 2015. P15396. AWARDED THIRD BEST POSTER PRESENTATION 3.Gupta G, Ahlawat R, Tiwari P. Prescription auditing for use of steroids in treatment of pediatric asthma- evidences from a cross-sectional study at a pediatric outpatient clinic. Proceedings of the 52nd Annual National Conference of the Indian Academy of Pediatrics (PEDICON); New Delhi, India; 2015. 4.Ahlawat R, Tiwari P, Gupta G. Antimicrobial utilization in gastrointestinal tract disorders: results from a private pediatric outpatient clinic. Poster presented at 4th Biennial Conference of Gastrointestinal Infection Society Of India (GISICON 2014); Chandigarh, India: GISICON; April 2014 5.Ahlawat R, Tiwari P, Gupta G. Evaluation of upper respiratory tract and acute gastroenteritis infections in children at a pediatric outpatient clinic in Northern India. Poster presented at 65th Indian Pharmaceutical Congress; 20-22 December; New Delhi, India: IPC; 2013. Poster No. L-1. 6.Ahlawat R, Tiwari P, Gaurav G. Pharmacoepidemiological profiling of acute gastroenteritis patients at an outpatient setting. Oral presentation at 64th Ind Pharm Cong, Chennai. Dec 7-9, 2012. AWARDED BEST PRESENTATION on merit 7.Ahlawat R, Gupta G, Tiwari P. Pharmacoepidemiology of Reactive Airways Disease among children at a paediatric outpatient setting of northern India. RESPICON (National Conference of IAP Respiratory Chapter), PGIMER, Chandigarh. Oct, 2012. 8.Ahlawat R, Gupta G, Tiwari P. Pharmacoepidemiological profiling of acute gastroenteritis patients at an outpatient setting. 64th Indian Pharmaceutical Congress, Chennai. Dec 2012. 9.Ahlawat R, Sneh lata, Gupta G, Tiwari P. Drug utilization review for childhood respiratory tract infections at a paediatric outpatient setting in northern India. 64th Indian Pharmaceutical congress, Chennai. Dec 2012. Poster no. H-96. 10.Ahlawat R, Tiwari P, Gaurav G. Utilization of fixed dose combinations in respiratory tract infection for children at an outpatient setting. Pediatric Conference of North India-2012, New Delhi. Oct, 2012. Poster No- 4 11.Gupta G, Tiwari P, Sneh Lata. Diagnostic Challenge in Vitamin B12 Deficiency, Pediatric conference of North India-2012, New Delhi. Oct, 2012. Poster No- 7 12.Ahlawat R, Tiwari P, Gaurav G. Pattern of prescribing at a paediatric outpatient setting in northern India. “PHARMVISION-2020”, Rajpura, March, 2012. Abstract No- 0046. 13.Singh H, Gupta G, Tiwari P. Safety and tolerability of trivalent inactivated influenza (TIV) vaccine in healthy Indian children. 62nd Indian Pharmaceutical Congress, 2010. Manipal, India. (Poster No. L-6). 14.Gupta A, Renuka R, Gupta G, Tiwari P. Prevalence of Gastrointestinal Disorders & Medication Prescription Pattern in Urban Paediatric Outpatient Setting. PGHANCON – Sept 2010 15.“Influenza Vaccine – Is it needed for Indian Children?” – 1st Influenza Foundation of India Conference (IFICON, 2010) 16.“Comparison Of Community Hospital Admissions With Tertiary Care Hospital”. National Pediatric Conference (PEDICON 2002) 17.“Pediatric Emergency Services At A Tertiary Care Hospital In India- A Patient Profile”. National Pediatric Conference (PEDICON 2002) 18.“Case Scenarios In Management Of Chronic Asthma” and “Case Scenarios In Prevention And Immunotherapy Of Asthma” in the 1st NATIONAL update on evidence-based management of Respiratory diseases in children (November 2000) 19. “Searching for Medical Information on the Internet” in the second NATIONAL conference of Medical Informatics (Feb 2000) ______________________________________________________________ PEDIATRIC RESEARCH IN OFFICE PRACTICE 1.Post Marketing Surveillance of routine use of Pentaxim (DTaP-IPV-Hib) vaccine administered as Primary or Booster dose to healthy children in India. (2009-2010) 2.The PRIDE Study - Pedimune in Recurrent Respiratory Infection and Diarrhoea- The Indian Experience. Ind J Pediatrics 2006 (73); p 585. www.medind.nic.in/icb/t06/i7/icbt06i7p585.pdf ______________________________________________________________ PUBLICATIONS INTERNATIONAL 1.Tiwari P, Ahlawat R, Gupta G. Evaluation of safety profile of yellow fever vaccine in healthy Indian travellers: a prospective observational study. J Pharma Care Health Sys. 2015;2(3):134. doi:10.4172/2376-0419.1000134. 2.Tiwari P, Ahlawat R, Gupta G. Antibiotic use for respiratory tract infections in children. Respirology. 2014;19:49. 3.Ahlawat R, Gupta G, Tiwari P. Complementary medicine causing severe side-effects in a child - an overlooked cause of weight loss? Int J of Pharm Sci and Res. 2014;5(8):478-9. 4.Ahlawat R, Tiwari P, Gupta G. Assessment of prescribing at a private pediatric outpatient setting in northern India. Asian J Clin Pediatr Neonatol. 2014;2(1):23-7. 5.Ahlawat R, Tiwari P, Gupta G. Direct Cost Involved in the Treatment of most Commonly Occurring Illness in Children at a Pediatric Outpatient Clinic in North India. Value in health: Journal of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2014; 17(3): A175. 6.Singh H, Rohit M, Gupta G, Bhasin P, Pahuja R. An Online Exploratory Study of Self Medication among Pharmacy graduates in India. Int. J. Drug Dev. & Res., Oct-Dec 2011, 3 (4): 200-207. 7.Singhi S, Jain V, Gupta G. Pediatric emergency admission profile in a tertiary care center. Journal of Tropical Pediatrics Aug 2003 NATIONAL 1.Tiwari P, Ahlawat R, Gupta G. Knowledge and Attitude of Travellers Regarding Yellow Fever Vaccination. IJOPP 10 (2), Apr 2017. DOI: 10.5530/ijopp.10.2.26. URL http://ijopp.org/article/538 Accessed in Aug 2017. 2.Tiwari P, Ahlawat R, Gupta G. Safety of yellow fever vaccine in Indian travellers: A prospective observational study. Indian J Med Res 144, Nov 2016, 778-780 DOI: 10.4103/ijmr.IJMR_1720_15 3.Author, IAP Guidebook on Immunization 2017 (to be published). Update on “Meningococcal Vaccines” 4.Author, IAP Guidebook on Immunization 2017 (to be published). "Setting up an immunization clinic - The minimum requirements". 5.Tiwari P, Ahlawat R, Gupta G. Pharmacoepidemiological profiling of acute gastroenteritis patients at a paediatric outpatient setting. Indian J Hosp Pharm. 2014;51(5):116-20. 6.Pramil T, Rajiv A and Gaurav G. Prescription practice in patients of upper respiratory tract infection at a pediatric outpatient clinic in Punjab. Indian Journal of Pharmacy Practice, 2014; 7(2):10-10 7.Gupta G, Tiwari P, Ahlawat R. A case of nimesulide toxicity in an Indian child. IJOPP. 2012;5(2): 57-58 8.Tiwari P, Ahlawat R, Gupta G. Pattern of prescribing at a pediatric outpatient setting in northern India. IJOPP. 2012; 5(1): 40-44 9.Gupta G. Acute Nitrobenzene Poisoning. Indian Pediatr 2000; 37: 1147-1148 (letter) 10.Gupta G. “Lure of the Internet-Technology Irresistible for Doctors” (Bulletin of Computer and Medical Education Group of the IAP) (April 2000) 11.Bi monthly CLIPPINGS (Journal abstracts) in Indian Pediatrics. Gupta G. July 2000; Sept 2000; Nov 2000; Jan 2001; Mar 2001; May 2001; July 2001; Sep 2001; Nov 2001; Jan 2002, March 2002; May 2002; July 2002; Sept 2002; Nov 2002; Jan 2003; March 2003; May 2003; July 2003; Sept 2003; Nov 2003; Quarterly CLIPPINGS in Indian Pediatrics Jan 2004 to Present (2012) 12.Gupta G. Scorpion sting – a case report. Published in INTENSIVIST (Bulletin of Intensive Care Group of the IAP) (Dec 2001) 13.Gupta G. Pediatric ICU Journal Abstracts. Published in INTENSIVIST (Bulletin of Intensive Care Group of the IAP) (Dec 2001) 14.Gupta G, Singh M, Bansal A. Antenatal carbamazepine use associated with d-TGA and ASD. Indian Pediatr 2002; 39: 101-102. 15.Gupta G. “Medscape – Website review”. (Bulletin of Computer and Medical education group of the IAP) (June 2002) 16.Gupta G. ‘Computer Software for Doctors’ in the book “Computer for Doctors” by IAP CME Group. Jaypee Publications 17.Gupta G. Delayed Milestones. Physician’s Digest. Integral media Pvt. Ltd. Feb-Mar 2007, Vol 15 No. 6. Pg 7-16. FACULTY at CONFERENCES ·Panel discussion: Leveraging social media for practice – Pedicon 2023 Teleconsultation - New Era of Office Practice (workshop) – Pedicon 2022 ·Advertising your practice using Office tools (Pre-conference Workshop), PEDICON 2020, Indore. ·Pediatric Research in Office Practice – Panelist, PEDICON 2020, Indore ·National Original Research Convention (NORC) – Research in Office Practice – My Story, New Delhi, Aug 2019. ·Integrating developmental pediatrics in office practice. Chandigarh. July 2017 ·PEDICON 2017. Cold Chain and Maintenance of Records. Bengaluru, Jan 2017 ·IAP Chandigarh Branch Annual meeting – Point of care testing in Pediatric Practice. Chandigarh, Dec 2016. · 3rd Pediatric Conference of North India (PCNI) – Smart use of the smart phone for the smart clinic. New Delhi, Dec 2016 ·6th Annual National Conference of the Infant and Young Child Feeding chapter of Indian Academy of Pediatrics (IYCFCON-2016) and 2nd Annual National Conference of the Human Milk Banking Association (HMBACON-2016), Oct 2016, Chandigarh. Topic: Challenges in Pediatric Obesity ·1st J&K State Medical Science Congress. ASCOM. Newer Vaccines – Driven by Science or Commerce. Jammu. May 2016 ·2nd Pediatric Conference of North India (PCNI) - Making Sense of your Clinic Data. New Delhi, Sep 2015. · 2nd Pediatric Conference of North India (PCNI) - Influenza Vaccine Update. New Delhi, Sep 2015. ·PEDICON 2015. NextGen Patient Care - Remote Patient Monitoring, How to use them in practice. 24th Jan 2015, New Delhi ·Wearable Health Devices – w26, PEDICON 2015, New Delhi ·Vaccine Safety – Pediatrician’s perspective. International Conference on Patient Safety, NIPER. March, 2012. ·IPV – Need of the hour. Haryana State PEDICON, Kurukshetra, Dec 2011. ·Influenza surveillance in India & Indian experience with Influenza vaccination. International Flu Update – 2011, Mumbai, August 2011. ·Flu vaccine – Utility in Teens. Symposia at National Adolescent Conference 2010, & HARCON (Annual Haryana State Conference, 2010), Gurgaon, Nov 2010. ·Preventing Cervical Cancer – IAP Karnal Meet, October 2010 ·12th Himachal State Pedicon, Shimla. Experts talk on Preventing Cervical cancer. September 2010 ·Pneumococcal 13 valent vaccine. IAP Chandigarh quarterly meet. September 2010 ·Hepatitis B vaccine: Choosing the Most Effective Schedule at VacXIM : Advances in Vaccinology, Goa – July 2010 ·Panelist – Influenza Vaccine – Pediatrician Perspective, 1st IFICON June 2010, Taj Hotel, New Delhi ·IAP Chandigarh meet on Preventive Pediatrics – May 2010 ·IAP Ludhiana Chapter meet on Cervical Cancer Prevention (Feb 2010) ·IAP Hissar Chapter meet on New Vaccines (Sept 2009) ·IAP Haryana PEDICON 2009-10, Sonepat – Newer Vaccines (Dec 2009) CONFERENCES ATTENDED ·Asia-Pacific Pediatric Vaccine Scientific Symposium, Ho Chi Minh City, Vietnam, June 2018 ·World Society for Pediatric Infectious Diseases Conference, Melbourne, Australia, Oct 2011 ·Asian Pneumococcal Disease Conference, Kuala Lumpur, July 2011 ·PGHANCON 2010 – PGIMER, Chandigarh, Sept 2010 ·IFICON 2010 (1st Influenza Foundation of India Conference) ·NATIONAL Pediatric Conferences (PEDICON 2002, 2007, 2008, 2019, 2020, 2021) ·First Single Theme Workshop on “Neonatal Sepsis” (Feb 2002) ·INTERNATIONAL CME in Pediatric Rheumatology (Dec 2001) ·First NATIONAL Update on Evidence-Based Management of Respiratory Diseases in Children (November 2000) ·Second NATIONAL conference on Medical Informatics (Feb 2000) ·First NATIONAL Conference on Medical Informatics (April 1999) ________________________________________________________________________ RESEARCH PROJECTS 1.Hair Iron Analysis In Normal And Thalassemic Children And Correlation With Serum Ferritin To Detect Iron Overload - Dissertation - 2.Phadke MA et al. Immunogenicity study of Haemophilus influenzae type B conjugate vaccine in Indian infants. Indian Pediatr 1997; 34: 779-83 3.ICMR Project: Prevalence of thalassemia trait in Antenatal mothers. 4.Modified DPT vaccine-immunogenicity and reactogenicity PERSONAL PROFILE Date of Birth 11th September 1972 Marital status Married Wife’s Name Dr. Poonam Gupta (Ophthalmologist) Language Known Hindi, English, Punjabi, Marathi Hobbies Medical Informatics, Online Medical Consultation, Artificial Intelligence, River rafting, Travel etc. Special Interests Travel Health, New Vaccines, Research in OPD Practice, Allergy & Asthma ________________________________________________________________________ I hereby solemnly declare that all the information provided here is as per the best of my knowledge. Dr. Gaurav Gupta

This doctor is not available for online consultations on the platform anymore.

Education:

Master of Dental Surgery

Professional Bio:

Dr. Partha Sarathi Adhya is a Dental Surgeon with three years of clinical experience. He was posted to NRS Medical College and Hospital as a House Surgeon. He has experience working under some of the best dental surgeons in West Bengal. He completed his MDS in Prosthodontics and Crown and Bridge in 2020. He is specialized in placing crowns and bridges, dentures, smile designing, and TMJ disorders. He has skilled hands in routine procedures like RCT, scaling, extraction, etc.

This doctor is not available for online consultations on the platform anymore.

Table of Contents

Introduction:

Yellow fever is a viral illness caused by arbovirus. It is transmitted through the bite of infected Aedes mosquitoes or through the bite of other ticks. The disease predominantly occurs in parts of South America and Africa. Symptoms can range from mild flu-like symptoms to severe manifestations such as fever, muscle pain, headache, loss of appetite, nausea, or vomiting. In severe cases, jaundice, hemorrhage, and multi-organ failure can be observed. Given the potentially severe health implications, yellow fever vaccination is vital for prevention.

Why Is Vaccination Essential?

The most effective way to prevent yellow fever is through vaccination. The yellow fever vaccine offers around 90 to 95 percent protection from this condition. After vaccination, within 10 days of the first dose, it provides lifelong immunity for most individuals. Besides personal protection, vaccination also contributes to herd immunity, reducing the overall transmission in at-risk communities.

Who Should Get Vaccinated?

Generally, the vaccine is recommended for:

  1. Travelers to areas with endemic or epidemic yellow fever.

  2. Residents living in high-risk zones.

  3. Laboratory workers who might be exposed to the virus.

However, not everyone is suitable for the vaccine. Infants under nine months old, pregnant women (unless the risk of infection is high), and individuals with severe allergies to egg protein or other vaccine components should generally avoid the vaccine.

How Is the Vaccine Administered?

The yellow fever vaccine is given as a single subcutaneous or intramuscular injection. A booster dose might be necessary for certain individuals, such as those who have received a stem cell transplant or have HIV.

What Are the Side Effects?

Side effects are generally mild and may include headaches, low-grade fever, and soreness at the injection site. Severe adverse reactions are rare but can include allergic responses or neurological complications.

  • Pre-Vaccination Tips for Home:

Before going for vaccination, here are some at-home tips:

  1. Consult the Physician: If someone has ongoing health conditions, consult the healthcare provider to assess suitability for the vaccine.

  2. Stay Hydrated: Adequate hydration can help to recover more quickly from the mild side effects that often accompany vaccinations.

  3. Check Allergy Status: If someone has known allergies, particularly to eggs, make sure to discuss this with the healthcare provider.

  4. Read Vaccine Guidelines: Familiarize with any guidelines or informational pamphlets provided to understand what to expect.

Vaccination against yellow fever is a straightforward yet crucial step in safeguarding public health, particularly for those traveling to or residing in high-risk areas.

  • Post-Vaccination Care:
  1. Monitor the Side Effects: As mentioned earlier, side effects are generally mild and may include headaches, fever, or muscle pain. Keep a symptom diary to track any adverse reactions post-vaccination. In some cases, mild rashes and itching can be seen.

  2. Manage Symptoms: Mild pain or fever can usually be managed with over-the-counter medications such as Acetaminophen. Consult the healthcare provider for advice tailored to the patient's health status.

  3. Stay Hydrated: As with pre-vaccination care, maintaining adequate hydration can aid recovery from any mild side effects. Also, adequate water and food intake before and after the vaccination is necessary.

  4. Report Severe Reactions: On rare occasions, severe adverse reactions can occur. If someone experiences any unexpected or severe symptoms, seek medical attention immediately.

  5. Avoid Mosquito Bites: Even after vaccination, it is crucial to take additional preventive measures, such as using insect repellents and sleeping under mosquito nets, particularly when traveling to endemic areas.

What Are Booster Shots?

The immunity conferred by the yellow fever vaccine is long-lasting. However, booster shots may be considered for specific populations, such as:

  1. People who were initially vaccinated before their first birthday.

  2. Individuals who have received hematopoietic stem cell transplants.

  3. Persons infected with HIV (human immunodeficiency virus) or suffering from AIDS (acquired immune deficiency syndrome).

What Are the Regulatory Requirements?

  1. International Certificate of Vaccination: Often, countries require proof of yellow fever vaccination for travelers coming from or transiting through endemic areas. This proof is provided as an International Certificate of Vaccination or Prophylaxis (ICVP), which becomes valid 10 days after vaccination and lasts for a lifetime for most people.

  2. Updates and Changes: Regulations and recommendations change, especially based on the epidemiology of yellow fever. Keep an eye on updated guidelines from health organizations and the embassy of the country traveling to.

  3. Local Regulations: Some countries may have additional requirements, such as booster shots. One should familiarize oneself with these specific regulations well ahead of the travel date.

What Are the At-Home Tips for Regulatory Compliance?

  1. Keep Records: Always keep the ICVP ( International Certificate of Vaccination or Prophylaxis) and any other vaccination records in a safe yet accessible place.

  2. Check Validity: Before traveling, ensure the vaccination certificate is up-to-date and readily available.

  3. Consult Travel Clinics: If someone is a frequent traveler, it may be beneficial to consult a travel health clinic for the most current advice on yellow fever and other travel-related health considerations.

Conclusion:

Yellow fever vaccination is essential for individuals living in or traveling to endemic regions. Being informed and taking appropriate steps before and after vaccination can help ensure not just your well-being but also smooth international travel. The fundamental aspects of the yellow fever vaccination drive include the importance of vaccination, identification of the recommended population for vaccination, and pre-vaccination care tips. The post-vaccination care includes the need for booster shots in specific populations and the various regulatory requirements associated with yellow fever vaccination. This may also include practical advice on managing symptoms post-vaccination, the importance of the International Certificate of Vaccination or Prophylaxis (ICVP), and steps for regulatory compliance.

Comprehensive Second Opinion

Ask your health query to a doctor online

Infectious Diseases

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.